Bridgeway Capital Management’s Shattuck Labs STTK Stock Holding History

Bridgeway Capital Management’s Portfolio STTK Stock Details STTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$294K	Hold	42,300	–	–	0.01%	980
2026 Q1	$272K	Hold	42,300	–	–	0.01%	958
2025 Q4	$154K	Hold	42,300	–	–	﹤0.01%	1062
2025 Q3	$101K	Sell	42,300 -50,000	-54%	-$61.2K	﹤0.01%	1112
2025 Q2	$73.1K	Buy	92,300 +55,000	+147%	+$53.3K	﹤0.01%	1105
2025 Q1	$35.4K	Sell	37,300 -37,000	-50%	-$45.6K	﹤0.01%	1138
2024 Q4	$89.9K	Sell	74,300 -31,600	-30%	-$39.1K	﹤0.01%	1121
2024 Q3	$370K	Buy	105,900 +68,600	+184%	+$256K	0.01%	927
2024 Q2	$144K	Hold	37,300	–	–	﹤0.01%	1119
2024 Q1	$333K	Sell	37,300 -12,800	-26%	-$117K	0.01%	1016
2023 Q4	$357K	Sell	50,100 -46,300	-48%	-$126K	0.01%	1024
2023 Q3	$147K	Hold	96,400	–	–	﹤0.01%	1152
2023 Q2	$301K	Buy	96,400 +11,200	+13%	+$32.5K	0.01%	1045
2023 Q1	$250K	Buy	85,200 +100	+0.1%	+$354	0.01%	1059
2022 Q4	$196K	Sell	85,100 -25,000	-23%	-$62.6K	0.01%	1097
2022 Q3	$297K	Buy	110,100 +71,700	+187%	+$269K	0.01%	1042
2022 Q2	$156K	Buy	+38,400	New	+$139K	﹤0.01%	1144

Other funds holding STTK

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

NCM

NEXTBio Capital Management Menlo Park, California $217M AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bridgeway Capital Management's STTK Position: Q2 2026 in Review

Bridgeway Capital Management held its Shattuck Labs (STTK) position steady in Q2 2026 at 42,300 shares worth $294K. The position accounts for 0.01% of the portfolio, ranked #980.

Bridgeway Capital Management first reported a position in STTK in Q2 2022 and has held it in 17 quarters since. The position peaked at $370K in Q3 2024. 100 funds tracked by Wall St. Rank hold STTK as of Q2 2026.

Bridgeway Capital Management held 42,300 shares of Shattuck Labs worth $294K as of Q2 2026.
Bridgeway Capital Management left its Shattuck Labs share count unchanged in Q2 2026.
Shattuck Labs made up 0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #980 holding.
Bridgeway Capital Management first reported a position in Shattuck Labs in Q2 2022 and has held it in 17 quarters since.
Bridgeway Capital Management's Shattuck Labs position peaked at $370K in Q3 2024.
100 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.